Could you provide the ref/details of this particular gene therapy and FDA views? I can understand why the FDA wants to move ahead slowly unless the condition is life-threatening or the impact is life-changing.
LinkedIn was a great platform, weaponized by Microsoft as the biggest security risk. There is no innovation for security, making it feature rich and more user friendly.